NCT05938283View on ClinicalTrials.gov

Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous)

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

January 10, 2026

Study Completion Date

January 10, 2026

Conditions
Implantable Defibrillator UserHypertrophic CardiomyopathyImplantable Cardioverter Ventricular Lead Dysfunction or ComplicationVentricular Arrythmia
Interventions
DEVICE

Implantable Cardioverter Defibrillator implant

ICD implant to protect patients from life threatening ventricular tachycardia or ventricular fibrillation

Trial Locations (1)

EC1A 7BE

RECRUITING

St Bartholomew's Hospital, London

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

collaborator

Queen Mary University of London

OTHER

lead

Barts & The London NHS Trust

OTHER